Algo version: 0.98b
GE Herbal Biotechnology is listed at the TWO Exchange
GE Herbal Biotechnology [4911.TWO]
TWO Sector: Healthcare Industry:Biotechnology

Is GE Herbal Biotechnology stock a buy?

What Is The Conclusion?

Right now our advanced algorithms say:

Do the analyst corps agree?

Interesting Questions and Easy Answers!

Yes, GE Herbal Biotechnology pays dividends. Last time was Thursday 12th of September 2024 where the investors holding the stock on Tuesday 20th of August 2024 were paid TWD0.6049 per share. Over the last 2 times between 2015 and 2024, GE Herbal Biotechnology has paid TWD0.7088 with an average of TWD0.35 per share.

Sorry, we do not have any analyst data for this ticker

We cannot find data for GE Herbal Biotechnology 10 years ago, but if you had invested on Friday 22nd of November 2019 when the price was TWD36.89, you would have made a profit of TWD18.21 per share or 49.36%

Yes, the average daily trading liquidity for GE Herbal Biotechnology is TWD46 633 thousand. You should therefore be able to get in and out of your positions relatively fast.

GE Herbal Biotechnology has no real debt, which is good in periods of high inflation. With a high cash flow to debt ratio of 20.20, the company's ability to pay off the debt is good. GE Herbal Biotechnology has a very good net profit margin of 39.48% and should have very high tolerances against inflation.

We have calculated the inflation risk for GE Herbal Biotechnology to be low [0 of 1]

US inflation for August 2024 was 0.19%. Over the last 12 months, the US inflation is 2.59%. The 10-year treasury yield that indicates the future interest level is currently 4.41 and is up 0.05 over the last 30 days.